Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: A review

Parkinsonism and Related Disorders

Volumn 17, Issue 6, 2011, Pages 413-417

  Broen, Martijn ^a   Duits, Annelien ^a,c,d   Visser Vandewalle, Veerle ^a,c,e   Temel, Yasin ^a,c,e,f   Winogrodzka, Ania ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e European Graduate School of Neuroscience   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Deep brain stimulation (DBS); Dopamine dysregulation syndrome (DDS); Drug replacement therapy (DRT); Impulse control disorder (ICD); Parkinson's disease (PD); Pathological gambling (PG); Punding; Subthalamic nucleus (STN)

Indexed keywords

ADULT; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COMPULSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MALE; NERVE CELL STIMULATION; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; REVIEW; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; TOTAL QUALITY MANAGEMENT;

ADULT; DEEP BRAIN STIMULATION; HUMANS; IMPULSE CONTROL DISORDERS; MIDDLE AGED; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 79959367266     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.02.013     Document Type: Review

References (56)

1. Ben-Shlomo Y. The epidemiology of Parkinson's disease. Parkinsonism 1997, 55-68. Balliere-Tindall, London. N.P. Quinn (Ed.).
2. Merims D., Giladi N. Dopamine dysregulation syndrome, addiction and behavioural changes in Parkinson's disease. Parkinsonism Relat Disord 2008, 14(4):273-280.
3. Truong D.D., Bhidayasiri R., Wolters E. Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci 2008 Mar 15, 266(1-2):216-228.
4. Ferreri F., Agbokou C., Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson's disease. CMAJ 2006 Dec 5, 175(12):1545-1552.
5. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord 2009 Dec, 15(Suppl. 3):S110-S113.
6. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010 May, 67(5):589-595.
7. Stamey W., Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist 2008 Mar, 14(2):89-99.
8. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 2007 Aug, 64(8):1089-1096.
9. Ardouin C., Voon V., Worbe Y., Abouazar N., Czernecki V., Hosseini H., et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006 Nov, 21(11):1941-1946.
10. Torta D.M., Castelli L. Reward pathways in Parkinson's disease: clinical and theoretical implications. Psychiatry Clin Neurosci 2008 Apr, 62(2):203-213.
11. Witjas T., Baunez C., Henry J.M., Delfini M., Regis J., Cherif A.A., et al. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation. Mov Disord 2005 Aug, 20(8):1052-1055.
12. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006 Jul, 63(7):969-973.
13. Zand R. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?. Eur Neurol 2008, 59(3-4):183-186.
14. Dodd M.L., Klos K.J., Bower J., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson's disease. Arch Neurol 2005 Sep, 62(9):1377-1381.
15. Ceravolo R., Fronsini D., Rossi C., Bonuccelli U. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord 2009, 15:111-115.
16. Gallagher D.A., O'Sullivan S.S., Evans A.H., Lees A.J., Schrag A. Pathological gambling in Parkinson's Disease: risk factors and differences from dopamine dysregulation. Mov Disord 2007, 22:1757-1763.
17. Limousin P., Krack P., Polak P., Benazzouz A., Ardouin C., Hoffmann D., et al. Electrical stimulation of the nucleus in advanced Parkinson's disease. N Engl J Med 1998 Oct 15, 339(16):1105-1111.
18. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006 Jun, 12(5):265-272.
19. Lu C., Bharmal A., Suchowersky O. Gambling and Parkinson disease. Arch Neurol 2006 Feb, 63(2):298.
20. Witjas T., Regis J., Delphini M. Dopamine dysregulation syndrome: impact of subthalamic chronic stimulation. Mov Disord 2007, 22(Suppl. 16):S182.
21. Houeto J.L., Mesnage V., Mallet L., Pillon B., Gargiulo M., du Moncel S.T., et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatr 2002, 72:701-707.
22. Smeding H.M.M., Speelman J.D., Koning-Haanstra M., Schuurman P.R., Nijssen P., van Laar T., et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006, 66:1830-1836.
23. Bandini F., Primavera A., Pizzorno M., Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat Disord 2007 Aug, 13(6):369-371.
24. Knobel D., Aybek S., Pollo C., Vingerhoets F.J.G., Berney A. Rapid resolution of dopamine dysregulation syndrome after subthalamic DBS for Parkinson disease. Cogn Behav Neurol 2008 Sep, 21(3):187-189.
25. Lim S.Y., O'Sullivan S.S., Kotschet K., Gallagher D.A., Lacey C., Lawrence A.D., et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009, 16:1148-1152.
26. Smeding H.M., Goudriaan A.E., Foncke E.M.J., Schuurman P.R., Speelman J.D., Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatr 2007 May, 78(5):517-519.
27. Hälbig T.D., Tse W., Frisina P.G., Baker B.R., Hollander E., Shapiro H., et al. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 2009 Apr, 16(4):493-497.
28. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviours in Parkinson disease. Neurology 2006 Oct 10, 67(7):1254-1257.
29. Avanzi M., Baratti M., Cabrini S., Uber E., Brighetti G., Bonfa F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006, 21(12):2068-2072.
30. Ondo W.G., Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008, 14(1):28-32.
31. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007, 64(2):212-216.
32. Brewer J.A., Potenza M.N. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008, 75(1):63-75.
33. Gerlach M., Double K., Arzberger T., Lebihuber F., Tatschner T., Riederer P. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003, 110(10):1119-1127.
34. Gurevich E.V., Joyce J.N. Distribution of dopamine D3 receptor expression neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 1999, 20(1):60-80.
35. Bharmal A., Lu C., Quickfall J., Crockford D., Suchowersky O. Outcomes of patients with Parkinson disease and pathological gambling. Can J Neurol Sci 2010 Jul, 37(4):473-477.
36. Mamikonyan E., Siderowf A.D., Duda J.E., Potenza M.N., Horn S., Stern M.B., et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008 Jan, 23(1):75-80.
37. Sohtaoglu M., Demiray D.Y., Kerangil G., Ozekmekci S., Erginoz E. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord 2010 Jun, 16(5):334-337.
38. Cilia R., Siri C., Marotta G., Isaias I.U., Gaspari D., Cenesi M., et al. Functional abnormalities underlying pathological gambling in Parkinson's disease. Arch Neurol 2008 Dec, 65(12):1604-1611.
39. Frank M.J. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Networks 2006, 19:1120-1136.
40. Lawrence A.D., Evans A.H., Lees A.J. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward system gone awry?. Lancet Neurol 2003, 2:595-604.
41. Muriel M.P., Agid Y., Hirsch E. Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease. Mov Disord 2001 May, 16(3):435-441.
42. Bejjani B.P., Arnulf I., Demeret S., Damier P., Bonnet A.M., Houeto J.L., et al. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?. Ann Neurol 2000 May, 47(5):655-658.
43. Nakano K. Neural circuits and topographic organization of the basal ganglia and related regions. Brain Dev 2000 Sep, 22(Suppl. 1):S5-S16.
44. Bevan M.D., Magill P.J., Terman D., Bolam J.P., Wilson C.J. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002 Oct, 25(10):525-531.
45. Temel Y., Blokland A., Steinbusch H.W., Visser-Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005 Aug, 76(6):393-413.
46. Hamani C., Saint-Cyr J.A., Fraser J., Kaplitt M., Lozano A.M. The subthalamic nucleus in the context of movement disorders. Brain 2004 Jan, 127(Pt 1):4-20.
47. Baunez C., Dias C., Amalric M., Cador M. The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards. Nat Neurosci 2005 Apr, 8(4):484-489.
48. Drapier D., Drapier S., Sauleau P., Haegelen C., Raoil S., Biseul I., et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol 2006 Aug, 253(8):1083-1091.
49. Frank M.J., Samanta J., Moustafa A.A., Sherman S.J. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007, 318:1309-1312.
50. Ballanger B., van Eimeren T., Moro E., Lozano A.M., Hamani C., Boulinquez P., et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009 Dec, 66(6):817-824.
51. Wylie S.A., Ridderinkhof K.R., Elias W.J., Frysinger R.C., Bashore T.R., Downs K.E., et al. Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain 2010 Dec, 133(Pt 12):3611-3624.
52. Salgado J.V., Malloy-Diniz L.F., Campos V.R., Abrantes S.S., Fuentes D., Bechara A., et al. Neuropsychological assessment of impulsive behaviour in abstinent alcohol-dependent subjects. Rev Bras Psiquiatr 2009 Mar, 31(1):4-9.
53. Castelli L., Perozzo P., Zibetti M., Crivelli B., Morabito U., Lanotte M., et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006, 55(3):136-144.
54. Lim S.Y., Evans A.H., Miyasaki J.M. Impulse control and related disorders in Parkinson's disease. Ann N Y Acad Sci 2008 Oct, 1142:85-107.
55. Weintraub D., Sohr M., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Arch Neurol 2010 Dec, 68(6):963-968.
56. Boon P., Dandachi-FitzGerald B., Duits A., Temel Y., Visser-Vandewalle V., Van den Hout M. Modification of emotional states by bilateral stimulation of the subthalamic nucleus in a patient with Parkinson's disease. J Neurol Neurosurg Psychiatr 2010 Jan, 82(1):117-118.